Shanghai Paran Data Technology Co., operating under the brand DataRx, specializes in providing advanced data governance and real-world evidence solutions tailored for the clinical research sector. The company serves pharmaceutical companies, healthcare providers, and research institutions by offering comprehensive data management services that ensure the quality and security of clinical data. DataRx operates in the healthcare and pharmaceutical market, focusing on the collection, analysis, and utilization of real-world data to generate actionable insights.

The business model revolves around offering subscription-based services and customized data solutions, leveraging artificial intelligence to enhance data collection and analysis processes. Revenue is generated through service contracts, data analysis projects, and long-term partnerships with clients. The company collaborates with recognized cloud service providers to ensure compliance with HIPAA regulations and maintain high standards of data security and quality control.

Key features include real-time data transfer, multi-end follow-up, and smart data interactive systems that facilitate rapid data import and efficient data analysis. These capabilities enable clients to rejuvenate historical empirical data and promote innovative applications of medical data.

Keywords: data governance, real-world evidence, clinical research, AI-driven methods, data quality, data security, healthcare, pharmaceutical, HIPAA compliance, cloud services.